Sunday, November 12, 2023
- 9:00AM-11:00AM
-
Abstract Number: 0074
Distinct PD-1 Receptor Engagement Leads to Different Pharmacodynamic Effects
(0066–0095) T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 0433
DMARD Initiation in Older Adults with New Diagnosis of Late-Onset Rheumatoid Arthritis
(0423–0459) RA – Treatments Poster I- 9:00AM-11:00AM
-
Abstract Number: 0282
DNA Methylation Markers in Peripheral Blood as Effective Diagnostic Biomarkers for Adult-onset Still’s Disease
(0252–0282) Miscellaneous Rheumatic & Inflammatory Diseases Poster I- 9:00AM-11:00AM
-
Abstract Number: 0296
Does Presence of Anti-SSa and Ro52 Influence the Progression of Interstitial Lung Disease (ILD) in Idiopathic Inflammatory Myopathies (IIM)
(0283–0307) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster I- 9:00AM-11:00AM
-
Abstract Number: 0616
Does Systemic Sclerosis Affect the Interpretation of Mammograms? A Retrospective Cohort Study
(0609–0672) Systemic Sclerosis & Related Disorders – Clinical Poster I: Research- 9:00AM-11:00AM
-
Abstract Number: 0515
Dose Adjustment of Tumor Necrosis Factor Inhibitors Does Not Correlated with Radiographic Progression in Patients with Ankylosing Spondylitis
(0510–0542) Spondyloarthritis Including Psoriatic Arthritis – Treatment: AxSpA Poster I- 9:00AM-11:00AM
-
Abstract Number: 0516
Drivers of Treatment Intensification in Patients with Axial Spondyloarthritis and High Disease Activity: Results from a Clinical Practice Registry
(0510–0542) Spondyloarthritis Including Psoriatic Arthritis – Treatment: AxSpA Poster I- 9:00AM-11:00AM
-
Abstract Number: 0458
Drug Switching Due to Inefficacy in Rheumatoid Arthritis Patients Treated with Biological and Targeted Therapies. Daily Clinical Experience
(0423–0459) RA – Treatments Poster I- 9:00AM-11:00AM
-
Abstract Number: 0602
Dual Blockade of ICOS and CD28 with Acazicolcept (ALPN-101) Reveals Non-Redundant Roles of T Cell Co-Stimulation Pathways in Systemic Lupus Erythematosus
(0582–0608) SLE – Treatment Poster I- 9:00AM-11:00AM
-
Abstract Number: 0499
Durability of Response Among Patients with Psoriatic Arthritis (PsA) Using Biological or Targeted Synthetic Disease-Modifying Antirheumatic Drugs in the CorEvitas PsA/Spondyloarthritis Registry
(0483–0509) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster I: PsA- 9:00AM-11:00AM
-
Abstract Number: 0266
E-selectin, ICAM-1 and ET-1 Biomarkers Address the Concern of the Challenging Diagnosis of Interstitial Lung Disease in Patients with Autoimmune Diseases
(0252–0282) Miscellaneous Rheumatic & Inflammatory Diseases Poster I- 9:00AM-11:00AM
-
Abstract Number: 0649
Early Systemic Sclerosis Definitions: Time to Rethink ‘Early’ in SSc Disease?
(0609–0672) Systemic Sclerosis & Related Disorders – Clinical Poster I: Research- 9:00AM-11:00AM
-
Abstract Number: 0470
Educational Intervention to Increase Contraception Screening and Documentation for Reproductive-Aged Women Seen in an Academic Rheumatology Clinic
(0460–0479) Reproductive Issues in Rheumatic Disorders Poster I